Undistributed funds worth over Rs 25,000 crore with Sebi in focus after death of Subrata Roy November 15th, 2023 12:27
Subrata Roy passed away in Mumbai on Tuesday night at the age of 75 after battling a prolonged illness.

Wipro stock gains 2% on voluntary liquidation of step-down subsidiary November 15th, 2023 12:27
Designit Tokyo, a step-down subsidiary of Wipro Limited, has been voluntarily liquidated with effect from November 13, 2023.

PC Jeweller Consolidated September 2023 Net Sales at Rs 449.17 crore, down 49.96% Y-o-Y November 15th, 2023 12:27
NULL

Ethos Consolidated September 2023 Net Sales at Rs 235.22 crore, up 32.35% Y-o-Y November 15th, 2023 12:27
NULL

Sigachi Ind Consolidated September 2023 Net Sales at Rs 99.18 crore, up 20.26% Y-o-Y November 15th, 2023 12:27
NULL

The case for loosening is getting stronger November 15th, 2023 12:27
As inflation eases, central banks now find themselves at the most difficult point in the policymaking cycle

NMDC trades in red even as Q2 net profit jumps 15%; brokerages remain upbeat November 15th, 2023 12:27
The NMDC stock has given a return of 64.22 percent over the last six months. The benchmark Nifty50 index has given a return of 5.68 percent over the same duration.

Renault#39;s EV unit Ampere targets 10 billion euros revenues in 2025 November 15th, 2023 12:27
The group set out financial targets for the unit, including an expected break-even in 2025 and an operating margin of at least 10% from 2030, ahead of an investor day meant to drum up support for the initial public offering slated for spring 2024.

FO Manual: Exuberance in Indian equity indices; analysts maintain moderately bullish stance on Nifty November 15th, 2023 12:27
The index has successfully held above the pivotal 19400 zone, a crucial factor in maintaining the current bias and sentiment. As per analysts, once a decisive move beyond the 19650 zone is established, a clear directional shift with conviction is anticipated

Gland Pharma gets tentative USFDA nod for blood pressure medication November 15th, 2023 12:27
Gland Pharma believes that it is the only company with first to file for this product and may be eligible for 180 days of generic drug exclusivity.